Encompass Health Corp incurred senior notes of $500 million in aggregate principal amount with Computershare Trust Company, National Association at 5.875% per annum maturing June 1, 2034.
“On May 29, 2026, Encompass Health Corporation (the “Company”) completed the issuance and sale of $500 million in aggregate principal amount of its 5.875% Senior Notes due 2034 (the “Notes”), along with the related guarantees of the Notes by certain of the Company’s subsidiaries (the “Guarantees”), in a private offering.”
Material Agreements
Encompass Health Corp entered into Indenture with Computershare Trust Company, National Association valued at $500 million (effective 2026-05-29).
“On May 29, 2026, Encompass Health Corporation (the "Company") completed the issuance and sale of $500 million in aggregate principal amount of its 5.875% Senior Notes due 2034 (the "Notes"), along with the related guarantees of the Notes by certain of the Company's subsidiaries (the "Guarantees"), in a private offering.”
Material Agreements
Encompass Health Corp entered into Purchase Agreement with Wells Fargo Securities, LLC, as the representative of the initial purchasers valued at $500,000,000 in aggregate principal amount of 5.875% senior notes due 2034 (effective 2026-05-14).
“On May 14, 2026, Encompass Health Corporation (the “Company”) and certain of its subsidiaries, as guarantors (the “Guarantors”), entered into a purchase agreement (the “Purchase Agreement”) with Wells Fargo Securities, LLC, as the representative of the initial purchasers (the “Initial Purchasers”), with respect to a private offering (the “Notes Offering”) by the Company of $500,000,000 in aggregate principal amount of 5.875% senior notes due 2034 (the “Notes”), along with the related guarantees of the Notes.”
Shareholder Votes
Encompass Health Corp shareholders approved Approval of the compensation of the Company’s named executive officers at the 2026-05-07 meeting.
“• Proposal 3, approval of the compensation of the Company’s named executive officers, passed:”
Shareholder Votes
Encompass Health Corp shareholders approved Ratification of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm at the 2026-05-07 meeting.
“• Proposal 2, ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm, passed:”
Shareholder Votes
Encompass Health Corp shareholders approved Election of the 10 persons nominated by the Company’s board of directors at the 2026-05-07 meeting.
“• Proposal 1, election of directors, each of the nominees was elected:”
Earnings Releases
Encompass Health Corp reported financial results for the three months ended March 31, 2026.
“On April 30, 2026, Encompass Health Corporation (“Encompass Health” or the “Company”) issued a press release reporting the financial results of the Company for the three months ended March 31, 2026.”
Debt Financings
Encompass Health Corp incurred revolving credit of $1 billion with Truist Bank at SOFR plus 3.00% maturing March 9, 2031.
“On March 9, 2026 (the “Closing Date”), Encompass Health Corporation (the “Company”) entered into the Credit Agreement (the “2026 Credit Agreement”), by and among the Company, certain of its subsidiaries, as guarantors, Truist Bank, as administrative agent and collateral agent, and various other lenders.”
Material Agreements
Encompass Health Corp entered into 2026 Collateral and Guarantee Agreement with Truist Bank, as collateral agent (effective 2026-03-09).
“Additionally, the Company terminated its existing collateral and guarantee agreement with Barclays and entered into the Collateral and Guarantee Agreement (the “2026 Collateral and Guarantee Agreement”), by and among the Company, certain of its subsidiaries, and Truist Bank, as collateral agent, which provides for similar terms in all material respects.”
Material Agreements
Encompass Health Corp terminated 2022 Credit Agreement with Barclays Bank PLC, as administrative agent and collateral agent, and various other lenders (effective 2026-03-09).
“As disclosed in Item 1.01 of this Current Report on Form 8-K, on March 9, 2026, the Company terminated the 2022 Credit Agreement and the Second Amended and Restated Collateral and Guarantee Agreement, dated November 25, 2019, by and among the Company, certain of its subsidiaries, and Barclays, as collateral agent.”
Material Agreements
Encompass Health Corp entered into 2026 Credit Agreement with Truist Bank, as administrative agent and collateral agent, and various other lenders valued at $1 billion (effective 2026-03-09).
“On March 9, 2026 (the “Closing Date”), Encompass Health Corporation (the “Company”) entered into the Credit Agreement (the “2026 Credit Agreement”), by and among the Company, certain of its subsidiaries, as guarantors, Truist Bank, as administrative agent and collateral agent, and various other lenders.”
Patrick W. Tuer was appointed as Executive Vice President and Chief Operating Officer at Encompass Health Corp.
“On April 24, 2025, Encompass Health issued a press release announcing the appointment of Patrick W. Tuer as Executive Vice President and Chief Operating Officer”
Earnings Releases
Encompass Health Corp reported financial results for the three months ended March 31, 2024.
“On April 24, 2024, Encompass Health Corporation (“Encompass Health” or the “Company”) issued a press release reporting the financial results of the Company for the three months ended March 31, 2024.”
Earnings Releases
Encompass Health Corp reported financial results for the three months and year ended December 31, 2023.
“On February 7, 2024, Encompass Health Corporation (“Encompass Health” or the “Company”) issued a press release reporting the financial results of the Company for the three months and year ended December 31, 2023.”
Edward M. Christie III was appointed as Director at Encompass Health Corp.
“the appointment of Edward M. Christie III as director to fill the newly created vacant seat.”
Earnings Releases
Encompass Health Corp reported financial results for three and nine months ended September 30, 2023.
“On October 26, 2023, Encompass Health Corporation (“Encompass Health” or the “Company”) issued a press release reporting the financial results of the Company for the three and nine months ended September 30, 2023.”
Earnings Releases
Encompass Health Corp reported financial results for three and six months ended June 30, 2023.
“On August 1, 2023, Encompass Health Corporation (“Encompass Health” or the “Company”) issued a press release reporting the financial results of the Company for the three and six months ended June 30, 2023.”
Shareholder Votes
Encompass Health Corp shareholders voted on Approval of the frequency of future votes to approve the compensation of the Company’s named executive officers at the 2023-05-04 meeting.
“• Proposal 4, approval of the frequency of future votes to approve the compensation of the Company’s named executive officers: Votes For 1 Year Votes For 2 Years Votes For 3 Years Votes Abstained 85,312,283 54,004 1,984,071 176,404”
Shareholder Votes
Encompass Health Corp shareholders approved Approval of the compensation of the Company’s named executive officers at the 2023-05-04 meeting.
“• Proposal 3, approval of the compensation of the Company’s named executive officers, passed: Votes For Votes Against Votes Abstained 82,107,798 5,282,269 136,695”
Shareholder Votes
Encompass Health Corp shareholders approved Ratification of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm at the 2023-05-04 meeting.
“• Proposal 2, ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm, passed: Votes For Votes Against Votes Abstained 90,134,778 2,507,596 97,423”
Shareholder Votes
Encompass Health Corp shareholders approved Election of the 11 persons nominated by the Company’s board of directors at the 2023-05-04 meeting.
“• Proposal 1, election of directors, each of the nominees was elected: Name of Nominee Votes For Votes Against Votes Abstained Greg D. Carmichael 84,221,239 3,193,614 111,909 John W. Chidsey 82,158,332 5,257,560 110,870 Donald L. Correll 82,458,694 4,957,043 111,025 Joan E. Herman 85,404,328 2,011,106 111,328 Leslye G. Katz 80,616,758 6,797,816 112,188 Patricia A. Maryland 85,208,415 2,207,660 110,687 Kevin J. O’Connor 85,705,974 1,710,617 110,171 Christopher R. Reidy 86,059,276 1,357,761 109,725 Nancy M. Schlichting 84,898,756 2,519,116 108,890 Mark J. Tarr 86,264,231 1,158,148 104,383 Terrance Williams 86,052,225 1,363,168 111,369”
Earnings Releases
Encompass Health Corp reported financial results for the three months ended March 31, 2023.
“On April 27, 2023, Encompass Health Corporation (“Encompass Health” or the “Company”) issued a press release reporting the financial results of the Company for the three months ended March 31, 2023.”
Earnings Releases
Encompass Health Corp reported financial results for the three months and year ended December 31, 2022.
“On February 7, 2023, Encompass Health Corporation (“Encompass Health” or the “Company”) issued a press release reporting the financial results of the Company for the three months and year ended December 31, 2022.”
Governance Changes
Encompass Health Corp: Board amended and restated bylaws to address Rule 14a-19 compliance, exclusive federal forum, officer structure refinements, expense advancement, virtual meetings, stockholder list, and adjournment of virtual meetings (effective 2022-12-08).
“On December 8, 2022, the board of directors (the “Board”) of Encompass Health Corporation (the “Company”) approved an amendment and restatement of the bylaws of the Company”
Kevin J. O’Connor was appointed as Director at Encompass Health Corp.
“the appointment of Kevin J. O’Connor as director”
Christopher R. Reidy was appointed as director at Encompass Health Corp.
“the appointment of Christopher R. Reidy as director.”
Christopher R. Reidy was appointed as Director at Encompass Health Corp.
“On August 31, 2021, the Board of Directors (the “Board”) of Encompass Health Corporation (the “Corporation”), unanimously approved, effective as of October 1, 2021, an increase in the number of directors constituting the Board of the Corporation from 14 to 15 and, upon the recommendation of its Nominating/Corporate Governance Committee, the appointment of Christopher R. Reidy as director to fill the newly created vacant seat.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.